Microperimetry and Optical Coherence Tomography (OCT) in Idiopathic Macular Hole

To evaluate the correlations between anatomical and functional changes studied with microperimetry (MPM) and spectral-domain OCT (SD-OCT) in patients after successful repair of idiopathic macular hole (MH).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Macular Hole Eye Diseases Retinal Diseases Retinal Perforations

Age range

55 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ophthalmology Department CHU Dijon

Dijon, Burgundy, 21000, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Closure of the hole seen on the OCT at 1 year postoperative

Exclusion criteria

Patients with an axial length over 26 mm, diabetes, macular diseases, glaucoma, or postoperative retinal detachment were excluded

Treatment and study plan

Microperimetry

Other

Primary outcomes

Macular sensitivity

Time frame: 12 months

To describre mean retinal sensitivity in the 12 and 4 central degrees of the retina in 23 patients one-year after macular hole surgery and thus to correlate macular sensitivities and retinal anatomic features in SD-OCT

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire Dijon

Other

Registry information

Official study title

Long-term Anatomical and Functional Outcomes of Idiopathic Macular Hole Surgery. The Yield of Spectral-domain OCT Combined With Microperimetry.

Important dates

Study start: 2010
Primary completion: 2010
First posted: Dec 31, 2012
Registry last updated: Dec 31, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed